AC
NEXI

Aaron Cowen’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Aaron Cowen’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,769
Closed -$5.21M – 116
2021
Q3 		$5.21M Sell
13,769
-861
-6% -$289K 0.09% 78
2021
Q2 		$5.97M Sell
14,630
-8,541
-37% -$3.93M 0.09% 89
2021
Q1 		$11.1M Buy
+23,171
New +$12.6M 0.16% 71

Other funds holding NEXI

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AO
Allen Operations New York $722M AUM 20.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Aaron Cowen's NEXI Position: Q4 2021 in Review

Aaron Cowen sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2021, closing a stake of 13,769 shares — an estimated $5.21M sold.

Aaron Cowen first reported a position in NEXI in Q1 2021 and held it in 3 quarters. The position peaked at $11.1M in Q1 2021. 46 funds tracked by Wall St. Rank hold NEXI as of Q4 2021.

  • Aaron Cowen reported no remaining NexImmune, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Aaron Cowen sold 13,769 NexImmune, Inc. Common Stock shares in Q4 2021, an estimated $5.21M.
  • Aaron Cowen first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Aaron Cowen's NexImmune, Inc. Common Stock position peaked at $11.1M in Q1 2021.
  • 46 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2021.

Based on Suvretta Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.